Xeno-free cryopreservation media are specialized formulations designed to preserve cells and tissues at ultralow temperatures without the inclusion of any components derived from non-human species. The term “xeno-free” (XF) denotes the absence of xenogeneic materials—components originating from a species different from the cell being preserved—while permitting human-derived components such as human serum albumin (HSA) or human serum. This distinguishes XF media from related but distinct classifications: serum-free media exclude serum but may contain animal-derived proteins; animal component-free (ACF) media exclude all animal-derived components but may permit human-derived materials; and chemically defined media contain only known components at defined concentrations.

The development of xeno-free cryopreservation media has been driven by the recognition that traditional formulations containing fetal bovine serum (FBS) pose substantial scientific, regulatory, and safety challenges. FBS is an ill-defined cocktail of proteins that varies considerably between lots, carries risks of contamination with zoonotic pathogens including viruses and prions, and introduces xenogeneic antigens that can provoke immunological reactions in patients receiving cell-based therapies. 

Applications

Xeno-free cryopreservation media are employed across diverse applications including cell therapy manufacturing (CAR-T cells, NK cells, MSCs), biobanking of human progenitor cells, stem cell research (PSCs, iPSCs), hepatocyte preservation for transplantation research, and tissue engineering. They are particularly critical for clinical translation, where regulatory requirements demand defined, xeno-free formulations that eliminate the risk of xenogeneic contamination and simplify regulatory filings.